SCHEMBL21031208

SCHEMBL21031208

Cc1cc(-c2ccc(-c3ccccc3)cc2)nc(-c2cccc(-c3ccccc3)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.53
KMT2A Q03164 8/20 0.53
MAPT P10636 7/20 0.53
KDM4E B2RXH2 6/20 0.53
ALDH1A1 P00352 6/20 0.53
HPGD P15428 4/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
TDP1 Q9NUW8 1/20 0.53
RAB9A P51151 3/20 0.50
AGTR1 P30556 1/20 0.49
ALDH1A3 P47895 2/20 0.47
ENPP3 O14638 2/20 0.47
SLC2A1 P11166 1/20 0.47
NPC1 O15118 1/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CTRC Q99895 1/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031207 0.98 MEN1 (0.52) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL19501120 0.96 MEN1 (0.48) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL17756652 0.92 MEN1 (0.60) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL16376441 0.92 MEN1 (0.60) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL4546989 0.91 MEN1 (0.57) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL18325403 0.90 MEN1 (0.54) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL23615528 0.89 MAPT (0.54) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL4546879 0.89 MEN1 (0.53) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL8756013 0.88 KMT2A (0.59) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL4546889 0.87 MEN1 (0.57) MEN1KMT2AMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885MAPT 611/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885MAPT 611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.